Back to Search
Start Over
Cutaneous side effects during therapy with Erlotinib: Case report
- Source :
- Scripta Medica, Vol 52, Iss 4, Pp 317-320 (2021)
- Publication Year :
- 2021
- Publisher :
- Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine, 2021.
-
Abstract
- Erlotinib is an antineoplastic drug used in the treatment of non-small cell lung cancer and pancreatic cancer. It is a potent, selective inhibitor of tyrosine kinase, a receptor for epidermal growth factor receptor (EGFR). Cutaneous side effects such as acneiform eruption, xerosis, telangiectasia, hair and nail changes are common. A case of a 70-year-old patient who developed unusual cutaneous side effects after 6 years of treatment with erlotinib was presented.
- Subjects :
- erlotinib
tyrosine kinase inhibitors
dermato-toxicity
Medicine
Subjects
Details
- Language :
- English, Serbian
- ISSN :
- 24903329 and 23037954
- Volume :
- 52
- Issue :
- 4
- Database :
- Directory of Open Access Journals
- Journal :
- Scripta Medica
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.9b5a4e0595e84b678f18bba4cfecab61
- Document Type :
- article
- Full Text :
- https://doi.org/10.5937/scriptamed52-35385